<?xml version="1.0" encoding="UTF-8"?>
<p>Study participants were enrolled from November 1, 2013 to October 31, 2015 among patients undergoing radiotherapy for non-metastatic and measurable HNC at the Department of Radiation Oncology in Seoul National University Hospital. All the recruited patients signed an informed consent. The subjects enrolled during the first 12â€Šmonths of the first year (November 1, 2013 to October 31, 2014) were assigned to the control group, and those from the second year (November 1, 2014 to October 31, 2015) to the experimental group. The participants were blinded after assignment to interventions. The flow diagram of this study was shown in Figure 
 <xref ref-type="fig" rid="F1">1</xref>. During the period of enrollment, there was no change of radiotherapy schema. Patients who were mentally incapacitated, with secondary or recurrent HNC, distant metastasis, skin cancer, congenital anomaly of the head and neck, chronic illness, or any previous or current psychiatric illness were excluded from the study. Those who had less than 20 teeth were also excluded. Those who were unable to answer the questionnaire due to senile dementia or severe intercurrent disease were also excluded. The hospitals staff who were not examiners, generated the allocation sequence, enrolled participants and assigned participants to experimental and control group.
</p>
